We are live on ! Find out more
EHI

Eagle Health Investments Portfolio holdings

AUM $603M
1-Year Est. Return 111.06%
This Fund
S&P 500
This Quarter Est. Return
+6.38%
1 Year Est. Return
+111.06%
3 Year Est. Return
+240.87%
5 Year Est. Return
+290.92%
10 Year Est. Return
–
AUM
$514M
AUM Growth
+$80.2M
Cap. Flow
+$80.5M
Cap. Flow %
15.67%
Top 10 Hldgs %
68.1%
Holding
30
New
3
Increased
9
Reduced
4
Closed
3

Top Buys

Rank Stock Value
1
LNTH icon
Lantheus
LNTH
+$18.4M
2
SRPT icon
Sarepta Therapeutics
SRPT
+$18M
3
GH icon
Guardant Health
GH
+$15.1M
4
ILMN icon
Illumina
ILMN
+$14.6M
5
PRCT icon
Procept Biorobotics
PRCT
+$10M

Top Sells

Rank Stock Value
1
CTLT
CATALENT, INC.
CTLT
+$14.8M
2
TNDM icon
Tandem Diabetes Care
TNDM
+$6.83M
3
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$3.99M
4
TXG icon
10x Genomics
TXG
+$1.79M
5
NTRA icon
Natera
NTRA
+$1.44M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BCYC
26
Bicycle Therapeutics
BCYC
$288M
$500K 0.1%
23,500
– –
LYEL icon
27
Lyell Immunopharma
LYEL
$365M
$236K 0.05%
5,000
– –
ARVN icon
28
Arvinas
ARVN
$588M
– –
-23,000
Closed -$787K
TXG icon
29
10x Genomics
TXG
$7.62B
– –
-49,200
Closed -$1.79M
CTLT
30
DELISTED
CATALENT, INC.
CTLT
– –
-329,100
Closed -$14.8M
1
2

Similar funds

IECM
Intrinsic Edge Capital Management Chicago, Illinois $603M AUM 66.97% 1-Year Est. Return
ERWM
Elk River Wealth Management Denver, Colorado $602M AUM 22.77% 1-Year Est. Return
CIG
Capricorn Investment Group Palo Alto, California $602M AUM 165.22% 1-Year Est. Return
JHCP
Jackson Hole Capital Partners Tulsa, Oklahoma $605M AUM 22.77% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
NPCM
North Peak Capital Management New York $601M AUM 0.2% 1-Year Est. Return
OCAM
Onex Canada Asset Management Toronto, Ontario, Canada $601M AUM 15.16% 1-Year Est. Return
GP
GSK plc London $599M AUM

Eagle Health Investments's Q1 2023 Portfolio in Review

As of Q1 2023, Eagle Health Investments held 30 positions worth $514M, up 19% from $433M the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Eagle Health Investments deployed $80.5M of net new capital in Q1 2023, opening 3 new positions and adding to 9 existing holdings. Its largest new stake was Lantheus: 284,800 shares worth $23.5M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

On the sell side, the largest reduction was Tandem Diabetes Care, an estimated $6.83M trimmed.

  • Eagle Health Investments's largest Q1 2023 buy was Lantheus: 284,800 shares worth $23.5M.
  • Eagle Health Investments added most to Guardant Health in Q1 2023, an estimated $15.1M increase.
  • Eagle Health Investments's biggest Q1 2023 reduction was Tandem Diabetes Care, cutting an estimated $6.83M.
  • Eagle Health Investments fully exited CATALENT, INC. in Q1 2023, selling an estimated $14.8M.
  • Eagle Health Investments's ten largest holdings make up 68% of its $514M portfolio in Q1 2023.
  • Eagle Health Investments opened 3 new positions and closed 3 in Q1 2023.
  • Eagle Health Investments's portfolio value rose 19% quarter-over-quarter to $514M.

Based on Eagle Health Investments's 13F filing for Q1 2023, filed 12 May 2023.